Skip to main content

Attention Medical School Students: Click this link to learn how to apply!

Attention Real Estate Licensees: The online supervision transactions (including sponsorship transfers and terminations) are currently unavailable due to a system maintenance update. All pending transactions will be processed and posted as soon as the system is back online. We apologize for the inconvenience.

Mario Treto, Jr., Secretary

Updated IDFPR Statement on Recent Court Rulings About Mifepristone

News Release – Monday, May 1, 2023

On Friday, April 21, 2023, the United States Supreme Court stayed the Texas court ruling which had stayed the 2000 FDA approval of Mifepristone pending litigation on the merits. The U.S. Supreme Court ruling means that Mifepristone remains a legal reproductive healthcare option for women in Illinois, as well as across the nation. The Illinois Department of Financial and Professional Regulation (“IDFPR”) will not discipline physicians who prescribe or pharmacists who fulfill prescriptions of Mifepristone.

Please click here to read the IDFPR statement.

Footer

Contact Information

Chicago Office
555 West Monroe Street, 5th Floor
Chicago, IL 60661

Springfield Office
320 West Washington Street, 3rd Floor
Springfield, IL 62786

Call Us: 1 (888) 473-4858

TTY/TDD Line: 1 (866) 325-4949

Stay Informed

Helpful Links